PCN Insights, News, Videos, and More

The “Principles of Psychopharmacology” session kicked off NP Institute In-Person on Friday afternoon, serving as a deep dive introductory course for advance practice providers (APPs).

The FDA approved ABILIFY ASIMTUFII (aripiprazole), a long-acting injectable (LAI) medication for the treatment of schizophrenia and bipolar I disorder. 

Results could mean screening for stress in high-risk older adults may be beneficial.

This is the first new protocol the board has released since 2006

Findings were presented at the annual meeting of the American Society for Biochemistry and Molecular Biology in Seattle in March

Preliminary findings from an observational follow-up study released by MAPS Public Benefit Corporation show that participants being treated for PTSD demonstrated a durable response at least 6 months after their last MDMA-assisted therapy...

Mothers with depression take longer to respond to their infant children than mothers without depression, according to a longitudinal study published in Infant and Child Development.